Most cited papers in Synthesis and biological activity
What are the most cited papers in Synthesis and biological activity?
The most cited paper in Synthesis and biological activity is "Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases" (Gary L. Johnson, Razvan Lapadat, 2002), with 4,334 citations. Next come "Multicomponent Reactions with Isocyanides" (4,073) and "A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases" (3,107).
Showing 50 of 100 papers. Every paper with more than 626 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases Gary L. Johnson, Razvan Lapadat · Science | 5 Dec 2002 | 4,334 |
| 2 | Multicomponent Reactions with Isocyanides Alexander S. S. Dömling, Ivar Ugi · Angewandte Chemie International Edition | 15 Sep 2000 | 4,073 |
| 3 | A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases Arup K. Ghose, Vellarkad N. Viswanadhan, John J. Wendoloski · Journal of Combinatorial Chemistry | 18 Dec 1998 | 3,107 |
| 4 | Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase Margaret F. Favata, Kurumi Y. Horiuchi, Elizabeth J. Manos et al. · Journal of Biological Chemistry | Jul 1998 | 3,045 |
| 5 | Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer Patrick J. Roberts, Channing J. Der · Oncogene | 14 May 2007 | 2,821 |
| 6 | The Properties of Known Drugs. 1. Molecular Frameworks Guy W. Bemis, Mark A. Murcko · Journal of Medicinal Chemistry | 1996 | 2,604 |
| 7 | Molecular Docking and Structure-Based Drug Design Strategies Leonardo L. G. Ferreira, Ricardo Nascimento dos Santos, Glaucius Oliva et al. · Molecules | 22 Jul 2015 | 2,578 |
| 8 | Molecular Docking: Shifting Paradigms in Drug Discovery Luca Pinzi, Giulio Rastelli · International Journal of Molecular Sciences | 4 Sep 2019 | 2,376 |
| 9 | Flavonoids: antioxidants or signalling molecules? Robert J. Williams, Jeremy P.E. Spencer, Catherine A Rice-Evans · Free Radical Biology and Medicine | 2 Feb 2004 | 2,021 |
| 10 | Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis Yu Sun, Wenzhou Liu, Tao Liu et al. · Journal of Receptors and Signal Transduction | 22 Jun 2015 | 1,922 |
| 11 | Ligand efficiency: a useful metric for lead selection Andrew L. Hopkins, Colin R. Groom, Alexander Alex · Drug Discovery Today | 23 Apr 2004 | 1,857 |
| 12 | THE FUNCTION OF CYTIDINE COENZYMES IN THE BIOSYNTHESIS OF PHOSPHOLIPIDES Eugene Paul Kennedy, Samuel B. Weiss · Journal of Biological Chemistry | Sep 1956 | 1,848 |
| 13 | Advances in Copper Complexes as Anticancer Agents Carlo Santini, Maura Pellei, Valentina Gandin et al. · Chemical Reviews | 8 Oct 2013 | 1,786 |
| 14 | A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications Nagaraju Kerru, Lalitha Gummidi, Suresh Maddila et al. · Molecules | 20 Apr 2020 | 1,719 |
| 15 | Role of Quinones in Toxicology Judy L. Bolton, Michael A. Trush, T.M. Penning et al. · Chemical Research in Toxicology | 23 Feb 2000 | 1,707 |
| 16 | A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Yuesheng Zhang, Paul Talalay, C G Cho et al. · Proceedings of the National Academy of Sciences | 15 Mar 1992 | 1,689 |
| 17 | Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17 Lars Ruddigkeit, Ruud van Deursen, Lorenz C. Blum et al. · Journal of Chemical Information and Modeling | 22 Oct 2012 | 1,584 |
| 18 | Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen Michael R. Boyd, Kenneth D. Paull · Drug Development Research | Feb 1995 | 1,565 |
| 19 | Esters of Methanesulfonic Acid as Irreversible Inhibitors of Acetylcholinesterase Richard J. Kitz, Irwin B. Wilson · Journal of Biological Chemistry | Oct 1962 | 1,525 |
| 20 | Chalcone: A Privileged Structure in Medicinal Chemistry Chunlin Zhuang, Wen Zhang, Chunquan Sheng et al. · Chemical Reviews | 10 May 2017 | 1,465 |
| 21 | Pharmacology of oleanolic acid and ursolic acid Jie Liu · Journal of Ethnopharmacology | Dec 1995 | 1,432 |
| 22 | Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial David Planchard, Egbert Frederik Smit, Harry J.M. Groen et al. · The Lancet Oncology | 11 Sep 2017 | 1,387 |
| 23 | Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity James Y. Tsai et al. · Proceedings of the National Academy of Sciences | 19 Feb 2008 | 1,368 |
| 24 | Prediction of the Biological Activity Spectra of Organic Compounds Using the Pass Online Web Resource Dmitry A. Filimonov, Alexey A. Lagunin, Tatyana A. Gloriozova et al. · Chemistry of Heterocyclic Compounds | 27 May 2014 | 1,347 |
| 25 | Benchmarking Sets for Molecular Docking Niu Huang, Brian K. Shoichet, John J. Irwin · Journal of Medicinal Chemistry | 26 Oct 2006 | 1,342 |
| 26 | Multicomponent reactions: advanced tools for sustainable organic synthesis Răzvan C. Cioc, Eelco Ruijter, Romano V. A. Orrù · Green Chemistry | 2014 | 1,332 |
| 27 | Biologically active dihydropyrimidones of the Biginelli-type — a literature survey Christian Oliver Kappe · European Journal of Medicinal Chemistry | Dec 2000 | 1,332 |
| 28 | H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor. Markus Meyer, Ralf Schreck, Patrick A. Baeuerle · The EMBO Journal | May 1993 | 1,322 |
| 29 | Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes Cláudio Viegas, Eliezer J. Barreiro, Carlos Alberto Manssour Fraga · Current Medicinal Chemistry | 30 Jun 2007 | 1,310 |
| 30 | 100 years of the biginelli dihydropyrimidine synthesis Christian Oliver Kappe · Tetrahedron | Aug 1993 | 1,226 |
| 31 | Biological Activities of Hydrazone Derivatives Sevım Rollas, Şükriye Güniz Küçükgüzel · Molecules | 17 Aug 2007 | 1,221 |
| 32 | p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases Sanjay Kumar, Jeffrey C. Boehm, John C. Lee · Nature Reviews Drug Discovery | Sep 2003 | 1,211 |
| 33 | Schiff bases: A short review of their antimicrobial activities Cleiton Moreira da Silva, Daniel L. da Silva, Luzia Valentina Modolo et al. · Journal of Advanced Research | 11 Jun 2010 | 1,197 |
| 34 | Fluorine in medicinal chemistry: A review of anti-cancer agents Chukwuemeka Isanbor, David O’Hagan · Journal of Fluorine Chemistry | 24 Feb 2006 | 1,121 |
| 35 | Recent Advances in the Biginelli Dihydropyrimidine Synthesis. New Tricks from an Old Dog Christian Oliver Kappe · Accounts of Chemical Research | 28 Sep 2000 | 1,101 |
| 36 | A review of anti-infective and anti-inflammatory chalcones Zdzisława Nowakowska · European Journal of Medicinal Chemistry | 16 Nov 2006 | 1,083 |
| 37 | Differential Activation of ERK and JNK Mitogen-Activated Protein Kinases by Raf-1 and MEKK Audrey Minden, Anning Lin, Martin McMahon et al. · Science | 9 Dec 1994 | 1,083 |
| 38 | Extended Functional Groups (EFG): An Efficient Set for Chemical Characterization and Structure-Activity Relationship Studies of Chemical Compounds E.S. Salmina, Norbert Haider, Igor V. Tetko · Molecules | 23 Dec 2015 | 1,045 |
| 39 | “Multi-component Reactions : Emerging Chemistry in Drug Discovery” ‘From Xylocain to Crixivan’ Christopher Hulme, Vijay Gore · Current Medicinal Chemistry | 2003 | 1,035 |
| 40 | Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review Khalid Karrouchi, Smaail Radi, Youssef Ramli et al. · Molecules | 12 Jan 2018 | 1,008 |
| 41 | Small Heterocycles in Multicomponent Reactions Benjamin H. Rotstein, Serge Zaretsky, Vishal Rai et al. · Chemical Reviews | 17 Jul 2014 | 1,008 |
| 42 | Natural and Synthetic Coumarin Derivatives with Anti-Inflammatory / Antioxidant Activities Konstantina C. Fylaktakidou, Dimitra Hadjipavlou‐Litina, Κonstantinos E. Litinas et al. · Current Pharmaceutical Design | Nov 2004 | 974 |
| 43 | 970 Million Druglike Small Molecules for Virtual Screening in the Chemical Universe Database GDB-13 Lorenz C. Blum, Jean‐Louis Reymond · Journal of the American Chemical Society | 8 Jun 2009 | 928 |
| 44 | New Method for Fast and Accurate Binding‐site Identification and Analysis Tom Halgren · Chemical Biology & Drug Design | Feb 2007 | 924 |
| 45 | Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial David Planchard, Benjamin Besse, Harry J.M. Groen et al. · The Lancet Oncology | 6 Jun 2016 | 897 |
| 46 | A review on recent developments of indole-containing antiviral agents Ming‐Zhi Zhang, Qiong Chen, Guang‐Fu Yang · European Journal of Medicinal Chemistry | 23 Oct 2014 | 888 |
| 47 | Apoptosis induced by anticancer drugs John A. Hickman · Cancer and Metastasis Reviews | Sep 1992 | 878 |
| 48 | Medicinal attributes of 1,2,3-triazoles: Current developments Divya Dheer, Virender Singh, Ravi A. Shankar · Bioorganic Chemistry | 18 Jan 2017 | 877 |
| 49 | Drugs, their targets and the nature and number of drug targets Peter Imming, Christian Sinning, Achim Meyer · Nature Reviews Drug Discovery | Oct 2006 | 857 |
| 50 | Antibacterial Activities of Flavonoids: Structure-Activity Relationship and Mechanism Yixi Xie, Weijie Yang, Fen Tang et al. · Current Medicinal Chemistry | 27 Sep 2014 | 855 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.